1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

20 Sep 2024
Admin
News Article

Axcelead DDP and Lilly Enter into Research and Collaboration Agreement

Overview

Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; “Axcelead DDP”) announced on September 5 that it has entered into a strategic research and collaboration agreement with Eli Lilly and Company (“Lilly”) for multiple drug discovery programs.

Axcelead DDP Developing Drug Candidates

Axcelead DDP generates drug candidates through its well-established drug discovery capabilities and innovative technologies, including AI.
Leveraging its researchers' deep knowledge and extensive experience, Axcelead DDP is positioned to drive innovative advancements in drug discovery.

Words from CEO: Axcelead DDP

“I am extraordinarily pleased to have entered into a strategic collaboration agreement with Lilly, a leading global pharmaceutical company. I firmly believe Lilly selected us as a drug discovery partner in recognition of our capabilities to generate new drug candidates and our wide-range novel drug discovery technologies,” said Kengo Okada, PhD., Representative Director and CEO of Axcelead DDP.
“We are dedicated to enhancing Lilly’s pipeline through our innovative drug discovery platform. Our goal is to deliver high-quality new drug candidates that have the potential to become the life-changing medicines of tomorrow, benefiting people worldwide.”

Under the terms of the agreement, Axcelead DDP will receive an upfront payment and is eligible to receive additional milestone payments based on the progress of each drug discovery program.

About Axcelead DDP

Axcelead DDP is Japan’s first drug discovery solution provider, established in July 2017 by inheriting the drug discovery platform from Takeda Pharmaceutical.
Screening, medicinal chemistry, pharmacology/biology, DMPK, and safety research functions are integrated into one center with a state-of-the-art research base and original compound library.
With the most advanced AI capability integration to Axcelead DDP’s service, Axcelead DDP can rapidly create high-quality drug candidates.
By leveraging these strengths, Axcelead DDP provides solutions to various challenges faced across drug discovery.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!